Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells.
Bachmann D, Aliperta R, Bergmann R, Feldmann A, Koristka S, Arndt C, Loff S, Welzel P, Albert S, Kegler A, Ehninger A, Cartellieri M, Ehninger G, Bornhäuser M, von Bonin M, Werner C, Pietzsch J, Steinbach J, Bachmann M. Bachmann D, et al. Among authors: albert s. Oncotarget. 2017 Dec 21;9(7):7487-7500. doi: 10.18632/oncotarget.23556. eCollection 2018 Jan 26. Oncotarget. 2017. PMID: 29484126 Free PMC article.
Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR".
Feldmann A, Arndt C, Bergmann R, Loff S, Cartellieri M, Bachmann D, Aliperta R, Hetzenecker M, Ludwig F, Albert S, Ziller-Walter P, Kegler A, Koristka S, Gärtner S, Schmitz M, Ehninger A, Ehninger G, Pietzsch J, Steinbach J, Bachmann M. Feldmann A, et al. Among authors: albert s. Oncotarget. 2017 May 9;8(19):31368-31385. doi: 10.18632/oncotarget.15572. Oncotarget. 2017. PMID: 28404896 Free PMC article.
A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform.
Albert S, Arndt C, Feldmann A, Bergmann R, Bachmann D, Koristka S, Ludwig F, Ziller-Walter P, Kegler A, Gärtner S, Schmitz M, Ehninger A, Cartellieri M, Ehninger G, Pietzsch HJ, Pietzsch J, Steinbach J, Bachmann M. Albert S, et al. Oncoimmunology. 2017 Feb 6;6(4):e1287246. doi: 10.1080/2162402X.2017.1287246. eCollection 2017. Oncoimmunology. 2017. PMID: 28507794 Free PMC article.
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells.
Mitwasi N, Feldmann A, Bergmann R, Berndt N, Arndt C, Koristka S, Kegler A, Jureczek J, Hoffmann A, Ehninger A, Cartellieri M, Albert S, Rossig C, Ehninger G, Pietzsch J, Steinbach J, Bachmann M. Mitwasi N, et al. Among authors: albert s. Oncotarget. 2017 Sep 18;8(65):108584-108603. doi: 10.18632/oncotarget.21017. eCollection 2017 Dec 12. Oncotarget. 2017. PMID: 29312553 Free PMC article.
Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model.
Pishali Bejestani E, Cartellieri M, Bergmann R, Ehninger A, Loff S, Kramer M, Spehr J, Dietrich A, Feldmann A, Albert S, Wermke M, Baumann M, Krause M, Bornhäuser M, Ehninger G, Bachmann M, von Bonin M. Pishali Bejestani E, et al. Among authors: albert s. Oncoimmunology. 2017 Jun 20;6(10):e1342909. doi: 10.1080/2162402X.2017.1342909. eCollection 2017. Oncoimmunology. 2017. PMID: 29123951 Free PMC article.
Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology.
Koristka S, Kegler A, Bergmann R, Arndt C, Feldmann A, Albert S, Cartellieri M, Ehninger A, Ehninger G, Middeke JM, Bornhäuser M, Schmitz M, Pietzsch J, Akgün K, Ziemssen T, Steinbach J, Bachmann MP. Koristka S, et al. Among authors: albert s. J Autoimmun. 2018 Jun;90:116-131. doi: 10.1016/j.jaut.2018.02.006. Epub 2018 Mar 2. J Autoimmun. 2018. PMID: 29503042
Radiomics workflow definition & challenges - German priority program 2177 consensus statement on clinically applied radiomics.
Floca R, Bohn J, Haux C, Wiestler B, Zöllner FG, Reinke A, Weiß J, Nolden M, Albert S, Persigehl T, Norajitra T, Baeßler B, Dewey M, Braren R, Büchert M, Fallenberg EM, Galldiks N, Gerken A, Götz M, Hahn HK, Haubold J, Haueise T, Große Hokamp N, Ingrisch M, Iuga AI, Janoschke M, Jung M, Kiefer LS, Lohmann P, Machann J, Moltz JH, Nattenmüller J, Nonnenmacher T, Oerther B, Othman AE, Peisen F, Schick F, Umutlu L, Wichtmann BD, Zhao W, Caspers S, Schlemmer HP, Schlett CL, Maier-Hein K, Bamberg F. Floca R, et al. Among authors: albert s. Insights Imaging. 2024 Jun 3;15(1):124. doi: 10.1186/s13244-024-01704-w. Insights Imaging. 2024. PMID: 38825600 Free PMC article.
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
Jensen TO, Murray TA, Grandits GA, Jain MK, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens R, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER; ACTIV-3/TICO Study Group. Jensen TO, et al. Lancet Microbe. 2024 May 27:S2666-5247(24)00015-6. doi: 10.1016/S2666-5247(24)00015-6. Online ahead of print. Lancet Microbe. 2024. PMID: 38815595 Free article.
1,118 results